Public Health Foundation Enterprises

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Public Health Foundation Enterprises sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials 2 currently recruiting 7 completed top decile by trial count

Public Health Foundation Enterprises: 11 sponsored US clinical trials, 2 recruiting.

Public Health Foundation Enterprises sponsors 11 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 7 completed. 3 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pre-exposure Prophylaxis, with 2 trials.

Top-decile sponsor footprint

Public Health Foundation Enterprises ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

11 total, page 1 of 1

RECRUITING Phase 2

PrEPsmart 2-1-1 Pilot

NCT06631365
RECRUITING NA

Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention

NCT04855773
ACTIVE NOT RECRUITING NA

The Cheeky Study: A Novel Delivery System for CAB-RPV LA

NCT05979714
TERMINATED NA

MyPrEP Plus: Development and Pilot Testing of Novel Preexposure Prophylaxis Decision Support Tools for Transgender Women

NCT07146139
COMPLETED NA

Comparison of Men's Prevention Apps to Research Efficacy

NCT03965221
COMPLETED Phase 4

DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men

NCT03771638
COMPLETED NA

LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing PrEP for Young Men Who Have Sex With Men

NCT03177512
COMPLETED Phase 4

DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence

NCT03387462
COMPLETED Phase 4

The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community

NCT03120936
COMPLETED NA

HOME Study: a Combination Support Package to Increase Uptake of PrEP and HIV/STI Testing

NCT03138135
COMPLETED Phase 1

Examining Hair to Determine Tenofovir Exposure

NCT00903084

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 4 3

Therapeutic Areas

Pre-exposure Prophylaxis 2
HIV Infections 2
Adherence, Medication 1
Transgender Persons 1
Sexually Transmitted Diseases 1
Risk Behavior 1
HIV Prevention 1
HIV-1-infection 1
HIV 1

What is open in the Public Health Foundation Enterprises pipeline

2 recruiting of 11 indexed (18% open); 7 completed (64%).

Phase mix: 3 late (III/IV) vs 2 early (I/II) (balanced across stages).

Top condition: Pre-exposure Prophylaxis (2 trials), 8 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Public Health Foundation Enterprises: open-pipeline peers nationwide

Peers matched on 11 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

Public Health Foundation Enterprises sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 10.910.91111.1 0%5%10%15%20% Total trials Recruiting share Public Health Foundation EnterprisesAderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiomeBurke Medical Research InstituteGrand Valley State UniversityImunonInventisBio Co.
Public Health Foundation Enterprises sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Public Health Foundation Enterprises sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Public Health Foundation Enterprises page

11 registered trials is a research-attention snapshot, not an endorsement of Public Health Foundation Enterprises or any single study.

  • 2 of Public Health Foundation Enterprises's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Pre-exposure Prophylaxis is the condition Public Health Foundation Enterprises studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pre-exposure Prophylaxis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Public Health Foundation Enterprises pipeline card: 11 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.